Report error Found 5 Enz. Inhib. hit(s) with all data for entry = 7712
TargetBeta-lactamase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Meiji Seika Pharma
US Patent
Meiji Seika Pharma
US Patent
Affinity DataIC50: 650nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
TargetBeta-lactamase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Meiji Seika Pharma
US Patent
Meiji Seika Pharma
US Patent
Affinity DataIC50: 650nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
TargetBeta-lactamase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Meiji Seika Pharma
US Patent
Meiji Seika Pharma
US Patent
Affinity DataIC50: 950nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
TargetBeta-lactamase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Meiji Seika Pharma
US Patent
Meiji Seika Pharma
US Patent
Affinity DataIC50: 3.00E+4nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
TargetBeta-lactamase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Meiji Seika Pharma
US Patent
Meiji Seika Pharma
US Patent
Affinity DataIC50: 3.00E+4nMpH: 7.0 T: 2°CAssay Description:For the measurement of β-lactamase inhibitory activity, 100 uM (final concentration) nitrocefin (Oxoid) was used as a substrate, and 2.5% DMSO, ...More data for this Ligand-Target Pair
